The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Nicotine receptor partial agonists for smoking cessation
Open accessAbstract
Nicotine receptor partial agonists for smoking cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of effective drugs to treat nicotine-dependence (e.g., nicotine patches, nicotine gum, and varenicline)356, 357) combined with counseling for psychological dependence increase the success rate of smoking cessation.”
From Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017 (2018) · cites this paper as [356]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,564
Self-citationAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
Pharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243
Self-citationAnthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Measures of abstinence in clinical trials: issues and recommendations
Hughes, J. R., Keely, J. P., NIAURA, R. S., Ossip-Klein, D. J., RICHMOND, R. L., & Swan, G. E. (2003) · Nicotine & Tobacco Research · doi:10.1093/ntr/5.1.13 · Cited by 1,058
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Flagged first, then by citations
Research works printed but not linked: 38
- Aubin, 2008, Authors' reply [to JE Rose], Thorax, 63, 752
- Aubin, 2008, Authors' reply [to T Hillman], Thorax, 63, 752
- Brinn, 2013, Cost effectiveness of an inpatient smoking cessation intervention for patients with tobacco related illnesses (Stop Trial): a multi-centre RCT [Abstract], Respirology (Carlton, Vic.), 18, 16 [O027]
- Carson, 2015, Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 24-month randomized controlled trial for inpatients, Respirology, 20, 115
- Carson, 2010, Varenicline tartrate and counselling versus counselling alone in a randomised controlled trial for inpatient smoking cessation: 3 month interim results [Abstract], Respirology, 15, A30
- Hnin, 2014, Triggers resulting in relapse: cohort analysis from the smoking termination opportunity for inpatients (STOP) trial [Abstract], Respirology (Carlton, Vic.), 19, 40 [TO 076]
- Anthenelli R Benowitz N West R St Aubin L McRae T Lawrence D Reports of suicidal ideation and behavior in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
- Benowitz N Evins AE West R St Aubin L McRae T Lawrence D EAGLES trial: study design and neuropsychiatric safety results Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- Prochaska J Neuropsychiatric risk concerns in the context of smoking, quitting, and cessation pharmacotherapy use Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- Prochaska J Benowitz N West R Anthenelli R Evaluating adverse events in a global smoking cessation study (EAGLES): a randomized controlled tiral comparing the safety and efficacy of the first-line smoking cessation aids in smokers with and without pychiatric disorders Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 7
- West R Benowitz N Evins AE St Aubin L McRae T Lawrence D Relative efficacy of varenicline, bupropion SR, and nicotine transdermal patch in aiding smoking cessation in the EAGLES trial Proceedings of the Society for Research on Nicotine and Tobacco, USA 3rd - 5th March 2016 8
- Bastian H Comment on Ebbert 2015 'Reduce to Quit' trial www.ncbi.nlm.nih.gov/pubmed/?term=25688780
- Evins, 2013, Extended duration pharmacotherapy with varenicline prevents relapse to smoking in adult smokers with schizophrenia, Neuropsychopharmacology, 38, S63
- Meszaros, 2012, Varenicline treatment of alcohol and nicotine dependence in schizophrenia: Problems encountered in a pilot trial, American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 21, 393
- Nakamura, 2007, Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers, Clinical Therapeutics, 29, 1040, 10.1016/j.clinthera.2007.06.012 · DOI
- Rigotti, 2010, A randomized trial of varenicline for smoking cessation in patients with cardiovascular disease: analysis of efficacy by baseline characteristics, Circulation, Conference, 2
- Benndorf, 1970, Smoking cessation treatment with cytisin (Tabex®): half-yearly outcomes for former smokers abstinent at four weeks from beginning of treatment, Das Deutsche Gesundheitwesen, 24, 774
- Benndorf, 1969, Further reports on a double blind trial of the Bulgarian cytisine compound Tabex® on 1214 smokers wishing to quit and practical experience in conducting clinics for such smokers, Das Deutsche Gesundheitswesen, 24, 1135
- Benndorf, 1968, Results of smoking cessation treatment with cytisin (Tabex®), Das Deutsche Gesundheitwesen, 23, 2092
- Scharfenberg, 1971, Cytisine (Tabex®) as a treatment for smoking cessation, Das Deutsche Gesundheitwesen, 26, 463
- O'Brien, 2007, Varenicline as maintenance therapy, Current Psychiatry Reports, 9, 348
- Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
- Fagerström, 2010, Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries, Current medical Research & Opinion, 26, 2165, 10.1185/03007995.2010.505130 · DOI
- Westergaard, 2014, The effect of varenicline on smoking cessation in a group of young asthma patients, American Journal of Respiratory and Critical Care Medicine, 189, A1091
- Reeves K Watsky E Williams K Azoulay S Billing B Gong J The safety of varenicline taken for 52 weeks for smoking cessation [RPOS3-54] Society for Research on Nicotine and Tobacco 12th Annual Conference Orlando Fla, USA 2006
- Falk, 2014, A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence, Alcoholism, Clinical and Experimental Research, 38, 139A
- Granatowicz, 1976, Smoking cessation through the use of cytisine and other therapy, World Smoking Health, 1, 8
- Hartwell, 2014, Pharmacogenetics of naltrexone and varenicline in heavy drinking smokers, Alcoholism, Clinical and Experimental Research, 38, 223A
- Bacvarov, 1967, Smoking cessation through medication: remarks on G. Scharfenberg, E Winkelvoss and S. Benndorf, Munch Med Wschr. 109 (1967) 1687-1689, Munchener Medizinische Wochenschrift, 109, 2663
- Kempe, 1967, Observation about the Bulgarian medicine for smoking withdrawal Tabex, produced by Pharmachim-Sofia, Savr Med, 18, 355
- Paun, 1968, [Smoking cessation with cytisine 'Tabex' tablets] [German], Sonderduck aus das deutsche Gesundheitwesen, 23, 2088
- Paun, 1970, Tabex: registering and treatment of smokers with chronic bronchitis in the consultation against tobacco smoking - Berlin, Medico-Biologic Information, 3, 15
- Shim, 2011, Varenicline treatment for smoking cessation in people with schizophrenia: a randomized double-blind placebo-controlled trial, Schizophrenia Bulletin, 37, 320
- Stoyanov, 1972, [On the therapeutic effectiveness and tolerability of Tabex] [Bulgarian], Savremenna Medicina, 23, 30
- Wiratmoko, 2013, Efficacy of varenicline, an nicotinic acetylcholine receptor partial agonist, vs placebo for smoking cessation. A randomized controlled trial, Respirology (Carlton, Vic.), 18, 66 [OS205]
- Reid, 2010, Varenicline versus transdermal nicotine patch for smoking cessation in patients with coronary heart disease: A pilot randomized trial, Canadian Journal of Cardiology, 26, 53D
- Smith, 2013, Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia, Neuropsychopharmacology, 38, S364
- Tutka, 2006, Cytisine - renaissance of well known alkaloid. Pharmacological aspects of efficacy in the treatment of tobacco dependence [Polish], Farmakoterapia w Psychiatrii i Neurologii, 1, 33
Cited by
Sorted by citations
Items 301–400 of 432
Úbeda, J. F. S.-V., Rodríguez-Vázquez, S., Barranco, J. A. O., Caldera, G. V., Alvárez, P. P. P., & Buitrago, F. (2019) · Family Practice · doi:10.1093/fampra/cmz005 · Cited by 3
Chiu, N., & Chang, C.-J. (2019) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_26_19 · Cited by 3
Development of Nicotine Loaded Chitosan Nanoparticles for Lung Delivery
Wang, H. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.108006 · Cited by 3
Spécificité du sevrage tabagique chez l’asthmatique et effets du sevrage sur l’asthme
Underner, M., Peiffer, G., Perriot, J., & Jaafari, N. (2021) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2020.11.003 · Cited by 2
Theodoulou, A., Lindson, N., Fanshawe, T. R., Thomas, J., Nollen, N. L., Ahluwalia, J. S., Leavens, E. L. S., & Hartmann‐Boyce, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015120 · Cited by 2
Self-citationDeng, M., Yang, Z. H., Ni, Y., Zhu, L., Xu, J., Zheng, L., & Zhou, B. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1142419 · Cited by 2
Diretrizes clínicas para cessação do tabagismo: análise comparativa com o agree ii
da Costa, A. P., Alves, B. M. C. S., da Silva, D. L. M., Martins, R. L. D. M., da Silva, F. A., Zimmermann, I. R., & Santana, R. S. (2022) · Brasília Médica · doi:10.5935/2236-5117.2022v59a285 · Cited by 2
Chenoweth, M. J., Kim, Y., Nollen, N. L., Hawk, L. W., Mahoney, M. C., Lerman, C. E., Knight, J., & Tyndale, R. F. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3210 · Cited by 2
Kaasgaard, D. M., Sørensen, M. K., Christiansen, R. B., Breum, U. N., Asiamah, N., Friis, L. B. T., & Hjorth, P. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2318305 · Cited by 4
Panagopoulos, V. N., Bailey, A., Kostopoulos, G., & Ioannides, A. A. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06556-2 · Cited by 3
Aktuelle Strategien der Raucherentwöhnung
Bölcskei, P., Davis-Wagner, P., Grundnig, J., & Pommer, P. (2013) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0032-1333053 · Cited by 2
Tobacco consumption, the forgotten factor in the calculation and approach of cardiovascular risk
Minué-Lorenzo, C., & Olano-Espinosa, E. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.07.018 · Cited by 2
Outpatient interventions for smoking cessation and reduction for adults with a mental disorder
Stockings, E., Black, N., Bartlem, K. M., Metse, A. P., Regan, T. W., Bailey, J. M., Wolfenden, L., Wiggers, J., & Bowman, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013286 · Cited by 3
Update on pharmacotherapy for smoking cessation
Choi, H. S., & Kim, J. Y. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.3.216 · Cited by 2
Nicotine and Cardiovascular Function
Ialongo, C., Sabatini, D., & Grassi, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_52 · Cited by 2
Current status of tobacco use, cessation and control policy in Korea
Lee, C. M. (2022) · Journal of Korean Medical Association · doi:10.5124/jkma.2022.65.12.789 · Cited by 3
Čivljak, M. (2022) · Acta Clinica Croatica · doi:10.20471/acc.2022.61.02.14 · Cited by 2
Kale, D., Pickering, A. D., & Cooper, A. J. (2023) · Journal of Substance Use · doi:10.1080/14659891.2023.2275015 · Cited by 2
Propuesta de abordaje terapéutico para el abandono del tabaco en pacientes hospitalizados
Bedolla-Tinoco, A., Ortíz-González, Y. G., García-Peña, L. E., Thirión-Romero, I. I., Robles-Hernández, R. E., Hernández‐Pérez, A., García‐Gómez, L., Osio-Echánove, J., & Pérez‐Padilla, R. (2024) · NCT Neumología y Cirugía de Tórax · doi:10.35366/119283 · Cited by 2
Berg, K. M., Jorenby, D. E., Baker, T. B., & Fiore, M. C. (2017) · The Journal of Smoking Cessation · doi:10.1017/jsc.2017.18 · Cited by 2
LUCA, R.-D. (2020) · FARMACIA · doi:10.31925/farmacia.2020.4.25 · Cited by 2
Factors Associated with Tobacco Cessation in Primary Health Care
Melnick, R., Rech, G. S., Rech, R. S., & Faustino‐Silva, D. D. (2021) · International Archives of Otorhinolaryngology · doi:10.1055/s-0040-1722164 · Cited by 2
Batra, A., Düerkop, M., Gertzen, M., Jähne, A., Mühlig, S., & Rüther, T. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00013-8 · Cited by 2
Effectiveness of stop smoking interventions among adults: an overview of systematic reviewsPreprint
Hersi, M., Beck, A., Hamel, C., Esmaeilisaraji, L., Pussegoda, K., Austin, B., Ahmadzai, N., Pratt, M., Thuku, M., Yazdi, F., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3743616/v1 · Cited by 2
Tobacco Use Disorder and Treatment
Fucito, L. M., & Baldassarri, S. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48565-4.00012-6 · Cited by 1
Dallery, J., Stinson, L. A., & Villegas, A. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-19964-6_41 · Cited by 1
Silver Spike Point Therapy in smoking cessation
Al-Zalabani, A. H. (2023) · Saudi Medical Journal · doi:10.15537/smj.2023.44.6.20220848 · Cited by 1
Interventions for smoking cessation in inpatient psychiatry settings
Plever, S., Kisely, S. R., Bonevski, B., Siskind, D. J., Yamazaki-Tan, J., Thaker, P., Vos, G., Kim, D., Guillaumier, A., & GARTNER, C. E. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015934 · Cited by 1
Terapia farmacológica de primera línea en cesación tabáquica
Benavides, M. G. (2024) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2024.07.001 · Cited by 1
Consenso de expertos sobre la organización de la asistencia al tabaquismo en España
Rábade, C., Riolobos, G. E., Cebrián, S., Díaz-Maroto, J. L., Lavesa, L. G., González-Béjar, M., Jimenez-Ruiz, C. A., Riesco, J. A., & Gutiérrez, R. D. S. (2025) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2025.102484 · Cited by 1
Genade, L., Steiner, L., Nabeemeeah, F., NIAURA, R. S., Nonyane, B. A. S., Hoffmann, C. J., Sohn, H., Kemp, C. G., Guastaferro, K., Mlambo, L. M., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.107985 · Cited by 1
Smoking Cessation Adjuncts Are Cost Effective Prior to Elective Revascularization
Nassereldine, H., Reitz, K. M., Lowenkamp, M. N., Madigan, M. C., Chaer, R. A., Tzeng, E., Smith, K. J., & Sridharan, N. D. (2025) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2025.08.016 · Cited by 1
Issa, J. S., Bellini, B. B., Ziotti, S. D. V., Abe, T. O., Arnaut, D., Alberto, R. L., Marcolin, M. A., & Tonstad, S. (2025) · Tobacco Prevention & Cessation · doi:10.18332/tpc/209189 · Cited by 1
Utilization of varenicline among Kansas Medicaid enrollees
Machado, N. M., Katz, A. J., Richter, K. P., & Ellerbeck, E. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333723 · Cited by 1
Translating Neurobiology into Practice in Tobacco, Alcohol, Drug, and Behavioral Addictions
Srivastava, A. B., & Gold, M. S. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00028-x · Cited by 1
Fernandes, R. R. A., Seixas, B. V., Szklo, A. S., Guerra, R. L., Barufaldi, L. A., de Albuquerque, R. D. C. R., & Vianna, C. M. D. M. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2021.07.005 · Cited by 1
Datla, S., & Jones, D. (2016) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738016674241 · Cited by 1
Pedro Peña, G., & Mónica Zagolin, B. (2017) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482017000300212 · Cited by 1
Choo, S. J., Chang, C. T., Tangiisuran, B., Latif, M. F. A., Sanusi, N. A., & Harun, S. N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19137757 · Cited by 1
Recent Trends of Research and Guidelines on Pharmacotherapy for Smoking Cessation
Kim, C.-Y. (2022) · Journal of the Korean Society for Research on Nicotine and Tobacco · doi:10.25055/jksrnt.2022.13.4.107 · Cited by 2
Deshabituación tabáquica: paciente y atención primaria, las claves. La medicación, una herramienta
García, R. M. (2023) · Atención Primaria · doi:10.1016/j.aprim.2023.102605 · Cited by 1
Therapie der Tabakabhängigkeit
Jähne, A., Mühlig, S., Rüther, T., & Batra, A. (2023) · Suchttherapie · doi:10.1055/a-2012-2499 · Cited by 1
Ardakani, M. T., Sani, Z. G., Beyraghi, N., Najarimoghadam, S., & Kheradmand, A. (2023) · Journal of Addictive Diseases · doi:10.1080/10550887.2023.2237395 · Cited by 1
Pérez‐Padilla, R., & Zabert, G. E. (2023) · Respirar · doi:10.55720/respirar.15.4.1 · Cited by 1
Rábade, C., Zamarrón-Sanz, C., Ameijeiras, Á. H., Abelleira‐Paris, R., Casal, A., Ferreiro, L., Rodríguez‐Núñez, N., Gabaldón, J. R., Toubes-Navarro, M. E., Álvarez-Dobaño, J. M., et al. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/183607 · Cited by 2
Liang, X., Tong, X., Miao, Y., Xue, X., Liu, A., & Guan, F. (2024) · Tobacco Induced Diseases · doi:10.18332/tid/186171 · Cited by 1
Khan, A., Tampi, R. R., & Tampi, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_16 · Cited by 1
Tabakentwöhnung – die bisher wenig genutzte Chance im ärztlichen Alltag
Vitzthum, K., Batra, A., Pankow, W., Raspe, M., Rupp, A., & Andreas, S. (2024) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2291-8145 · Cited by 1
Swanson, M., Masclans, L., & Davis, J. M. (2025) · Tobacco Prevention & Cessation · doi:10.18332/tpc/194629 · Cited by 1
Johnstone, S., Cooper, R. K., Wray, J. M., Tonkin, S., Knapp, K. S., Colder, C. R., Maguin, E., Mahoney, M. C., Tiffany, S. T., Brandon, T. H., et al. (2025) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntaf100 · Cited by 1
Drovandi, A. D., Teague, P.-A., Glass, B. D., & Malau‐Aduli, B. S. (2017) · The Journal of Smoking Cessation · doi:10.1017/jsc.2017.17 · Cited by 1
C(5) Site-Selective Functionalization of (S)-Cotinine
Campello, H. R., & Gallagher, T. C. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b02704 · Cited by 1
The Orexin System and Nicotine Addiction: Preclinical Insights
Khoo, S. Y., McNally, G. P., & Clemens, K. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00061-7 · Cited by 1
Lee, J. H., & Lee, E. S. (2019) · Korean Journal of Stress Research · doi:10.17547/kjsr.2019.27.4.298 · Cited by 1
Tabakentwöhnung bei peripherer arterieller Verschlusskrankheit
Frey, S., Burkard, T., & Meienberg, A. (2020) · Gefässchirurgie · doi:10.1007/s00772-020-00627-2 · Cited by 1
Arrêt du tabac : comment mieux impliquer le patient dans le choix du traitement
Sadowski, I. J., Rat, C., Selby, K. J., & Cornuz, J. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2018.06.012 · Cited by 2
Prevention of Stroke by Modification of Additional Vascular and Lifestyle Risk Factors
Towfighi, A., & Saver, J. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316286234.018 · Cited by 1
Douglas, A., & Ahmed, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821573-9.00016-3 · Cited by 1
Population pharmacokinetics and exposure–response analyses of varenicline in adolescent smokers
Fediuk, D. J., Sweeney, K., Sahasrabudhe, V., McRae, T. D., & Byon, W. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12645 · Cited by 1
Therapie der Tabakabhängigkeit
Jähne, A., Mühlig, S., Rüther, T., & Batra, A. (2021) · PSYCH up2date · doi:10.1055/a-1228-0881 · Cited by 1
Bauer, A., Leone, F. T., Rogers, T., Wollack, C., Stevens, N., Purnell, J., Quinn, M. H., An, M., Jenssen, B. P., & Schnoll, R. A. (2021) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2021.100006 · Cited by 1
Common Risk Factors and Prevention
Brainin, M., Teuschl, Y., & Matz, K. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108659574.008 · Cited by 1
Varenicline Treatment for Waterpipe Smoking Cessation
Chami, H. A., Zaouk, N., Makki, M. H., Tamim, H., Shaya, M., & Talih, F. R. (2022) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntac162 · Cited by 1
Ex-smokers referred urgently to ENT: reasons for quitting and smoking cessation methods utilised
Dibor, C., Lim, A. E., & Montgomery, J. (2023) · Journal of Substance Use · doi:10.1080/14659891.2022.2140717 · Cited by 1
Supporting smokers’ quit attempts reduces national smoking prevalence
Coleman, T. J. (2019) · Thorax · doi:10.1136/thoraxjnl-2019-213265 · Cited by 1
Investigating the Drivers of Smoking Cessation: A Role of Alternative Nicotine Delivery Systems?Preprint
Hampsher, S., & Prieger, J. E. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3773201 · Cited by 1
Addictions and Substance Misuse
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg004 · Cited by 1
The development and evaluation of a smoking cessation referral aid for the primary care setting
Zijlstra, D. N. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220210dz · Cited by 1
How Varenicline Works: Identifying Critical Receptor and Ligand-based InteractionsPreprint
Aiken, S., Fiorito, D., Harper, M., Pikus, G., Underhill, J., Murray, J., Rawlinson, J., O’Donoghue, A. C., Gotti, C., Lummis, S. C. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.14.659675 · Cited by 1
Francis, C., & Parmar, V. S. (2017) · Journal of Psychiatry and Psychiatric Disorders · doi:10.26502/jppd.2572-519x001
Hering, T. (2018) · InTech eBooks · doi:10.5772/intechopen.70565
Psychopharmacology in Rural Settings
Praharaj, S. K., & Andrade, C. (2019) · Studies in computational intelligence · doi:10.1007/978-981-10-0751-4_17-1
Nuevas estrategias farmacológicas para el tratamiento de cesación de tabaco
Gabriel, K. L., & Vargas, V. Q. (2019) · Revista Medica Sinergia · doi:10.31434/rms.v4i6.246
Varenicline: Treating Smoking Addiction and Schizophrenia
Jung, D.-U., & Kim, S.-J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813035-3.00056-3
Nicotine and Cardiovascular Function
Ialongo, C., Sabatini, D., & Grassi, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-90305-7_52-1
Drugs to Treat Substance Use Disorders
Sinclair, J., & Peters, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.017
A meta-analysis of cocaine use disorder treatment effectivenessPreprint
Bentzley, B. S., Han, S. S., Stein, S. C., Neuner, S., Humphreys, K. N., Kampman, K. M., & Halpern, C. H. (2020) · medRxiv · doi:10.1101/2020.06.09.20127142
Varenicline for smoking cessation in young people: is there more we need to know?
Morphett, K., & Connor, J. P. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30305-9
E-cigarettes for smokers trying to quit
Tonstad, S. (2020) · European Respiratory Journal · doi:10.1183/13993003.02934-2020
Commentary on Thomas et al.: Are simple solutions to complex problems possible?
Bonevski, B., & Walker, N. K. (2021) · Addiction · doi:10.1111/add.15433
Madden, B. J., & Fogger, S. A. (2021) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000403
Nikkholgh, A., Ebrahimi, S. A., Bakhshi, E., Zarrindast, M., Asgari, Y., & Torkaman‐Boutorabi, A. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.1552.1
Robson, D., & McNeill, A. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781911623199.013
Tabakentwöhnung – die bisher wenig genutzte Chance im ärztlichen Alltag
Vitzthum, K., Batra, A., Pankow, W., Raspe, M., Rupp, A., & Andreas, S. (2022) · Pneumologie · doi:10.1055/a-1524-4478
Psychopharmacology in Rural Settings
Praharaj, S. K., & Andrade, C. (2020) · Mental health and illness worldwide · doi:10.1007/978-981-10-2345-3_17
Eriksen, M. P., & Whitney, C. F. (2013) · Oxford University Press eBooks · doi:10.1093/obo/9780199756797-0116
David, T., & Humphries, C. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.tc_overview
(2016) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2016.7.0410
Pohunek, P. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734219257.793552532
Tabakentwöhnung als Ausbildungsziel im Medizinstudium
Herold, R. (2022) · doi:10.53846/goediss-9242
Behandlung von schädlichem und abhängigem Tabakkonsum
Andreas, S., Batra, A., Brüggmann, D., Geyer, D., Gohlke, H., Hering, T., Jähne, A., Jückstöck, J., Klein, M., Kotz, D., et al. (2022) · Springer eBooks · doi:10.1007/978-3-662-63679-4_4
Guijarro, A. B., & García, M. Á. C. (2022) · Farmacéuticos Comunitarios · doi:10.33620/fc.2173-9218.(2022/vol14).003.04
Health recommender systems for behavior change
Hors-Fraile, S. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220324sh
Gobarani, R. K., Weeks, G. R., Abramson, M. J., Bonevski, B., Paul, E. M., Webb, A. R., Kirsa, S. W., Smith, B. J., Thomas, D., Perinpanathan, S., et al. (2022) · Health Promotion Journal of Australia · doi:10.1002/hpja.658
Evaluation of factors affecting smoking cessation in people treated with Varenicline
Köksal, N. G., & Sağlam, Z. A. (2022) · Medical Science and Discovery · doi:10.36472/msd.v9i9.805
Ismail, N. R., Awang, H., Rahman, N. J. A., Daud, A. A., Zulrushdi, M. F., Zainuddin, A., Rahman, M. A. A., & Embong, K. (2022) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2022.4.6.1476
Metadata
- Authors
- Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R., & Lancaster, T.
- Affiliations
- University of Oxford (GB)
- University of Oxford; Nuffield Department of Primary Care Health Sciences; Radcliffe Observatory Quarter Woodstock Road Oxford UK OX2 6GG
- University of Bristol (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-05-09
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4294253676
- Cited by
- 433
- References
- 230
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 32 · 2023: 57 · 2022: 55 · 2021: 65 · 2020: 34 · 2019: 52 · 2018: 49 · 2017: 43 · 2016: 8
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Update notices
- new_version (2023-05-05)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion)
- Explore Bristol Research (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research (15/58/18, HTA/15/58/18, CL-2013-25-003)
- Academy of Medical Sciences (AMS-SGCL12-Thomas)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- nicotine receptor partial agonist, smoking cessation, nicotine replacement therapy, varenicline, bupropion, nicotine dependence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
